Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-012684·Cadrenal Therapeutics, Inc.
Schedule 13G ownership disclosure
Cadrenal Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 127636207
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Havlickova 648 a.s.
Shares: 78,291.00 · Class: 4.39%
- Dubnica Property s.r.o.
Shares: 78,291.00 · Class: 4.39%
- Miroslav Dornak
Shares: 78,291.00 · Class: 4.39%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-012684
- Form type
- SCHEDULE 13G/A
- Filer
- Cadrenal Therapeutics, Inc.
- CIK
- CIK 1937993
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership